Connection between Breast and Ovarian Cancer: Identified Links and Risk Factors
Established Link Between Breast and Ovarian Cancer
A robust association exists between breast and ovarian cancers, predominantly due to genetic factors. Individuals carrying mutations in the BRCA1 and BRCA2 genes stand at a higher risk of developing both cancers.
The genetic risk factors shared by these cancers can increase the incidence of both diseases. People bearing these genetic risks may potentially develop both types of cancer.
Factors linking breast and ovarian cancers range beyond the genetic. Age, overweight or obesity, and never carrying a pregnancy to term are other common risk factors. Some of these risk factors, such as weight management, can be influenced by personal choices.
Individuals who have previously battled breast cancer face a heightened risk of ovarian cancer. This elevated risk is particularly pronounced in cases linked to BRCA1 or BRCA2 gene mutations. The increased risk is attributed to underlying genetic factors rather than the disease itself.
Additionally, ovarian cancer patients may have an approximately 1.6-fold increased risk of subsequent breast cancer. However, the risk fluctuates with the time elapsed since their initial cancer diagnosis.
Mutations in the BRCA1 and BRCA2 genes are the most significant shared risk factors. Approximately 60% of families with both ovarian and breast cancer carry BRCA1 gene mutations, while about 20% have BRCA2 mutations.
Other shared risk factors for breast and ovarian cancers may include:
- Family history of either cancer
- Older age, with ovarian cancer typically occurring in those over 40 years, and breast cancer in individuals aged 55 years or older
- Overweight or obesity
- Having a first child over the age of 30
- Never having children
- Not breastfeeding
- Hormone therapy after menopause
To reduce the risk of breast and ovarian cancer, some risk factors, such as a family history, cannot be changed. However, healthcare professionals may recommend careful monitoring, lifestyle changes, and preventive medical procedures for managing these unchangeable factors.
Those at increased risk due to a history of breast or ovarian cancer may be advised to undergo frequent and thorough screenings. Regular mammograms, breast MRI scans, pelvic exams, transvaginal ultrasounds, and CA-125 blood tests can help early detection and treatment. Genetic testing for BRCA1, BRCA2, and other relevant mutations is often the best strategy for effective monitoring and prevention.
For those carrying genetic mutations, doctors may consider additional options such as prophylactic surgeries to remove potentially cancerous organs or tissue.
Modifiable risk factors include:
- Achieving and maintaining a moderate weight
- Regular exercise
- Limiting alcohol intake
- Discussing contraception options with a healthcare provider
The outlook for those diagnosed with both primary breast cancer and primary ovarian cancer is relatively favorable, with 5- and 10-year overall survival rates of around 90%. The outlook is more positive when the interval between the two diseases is longer. However, ovarian cancer following breast cancer often involves a later-stage diagnosis, which can negatively affect survival.
Individuals with concerns about their personal risk or outlook should consult their healthcare team. Regular vigilance for signs of recurrence or a second cancer after a previous diagnosis is essential for early detection and prompt treatment.
For more evidence-based information and resources on cancer, visit our dedicated hub.
People with ovarian cancer may have an increased risk of various cancers, including bladder, bile duct, colorectal, acute leukemia, and melanoma of the eye. Breast cancer can metastasize to the ovaries, although such occurrences are relatively uncommon.
People at high risk of ovarian cancer may carry BRCA1 or BRCA2 gene mutations, have a family history of ovarian, breast, or colorectal cancer, have Lynch syndrome, endometriosis, never been pregnant, or have had a late first pregnancy.
In summary, genetic factors, especially mutations in BRCA1 and BRCA2 genes, play a crucial role in the association between breast and ovarian cancers. People with these mutations have significantly higher risks of developing both cancers. Additionally, a personal or family history of one cancer increases the risk of developing the other, emphasizing the importance of genetic testing, regular screenings, and preventive measures for those at higher risk.
- Individuals carrying BRCA1 and BRCA2 gene mutations have a higher risk of developing both breast and ovarian cancers.
- Factors like age, overweight or obesity, never carrying a pregnancy to term, and hormone therapy after menopause can increase the risk of developing both breast and ovarian cancers.
- People with a history of breast cancer may have an elevated risk of ovarian cancer, particularly those with BRCA1 or BRCA2 gene mutations.
- Ovarian cancer patients may have an approximately 1.6-times increased risk of subsequent breast cancer.
- To manage the risk of breast and ovarian cancer, healthcare professionals may recommend regular screenings, lifestyle changes, and preventive medical procedures.
- Modifiable risk factors for breast and ovarian cancers include achieving and maintaining a moderate weight, regular exercise, limiting alcohol intake, and discussing contraception options with a healthcare provider.
